Ettore D'Argento

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Ngā mahi tauwhiro me te tika pāpori o te Māori (Māori social work and social justice)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 17, 2025
Correction: Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Fabiana Letizia Cecere, Ettore D'Argento, Francesco Gelsomino

|Nov 17, 2025
Capmatinib for the treatment of METex14 skipping non-small cell lung cancer: retrospective analysis of real-world data from patients receiving compassionate use treatment in Italy.

Fabiana Letizia Cecere, Ettore D'Argento, Francesco Gelsomino

|Jan 22, 2024
Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR Inhibitors.

Eleonora De Luca, Pietro Sollena, Lucia Di Nardo

|Nov 11, 2022
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics.

Marco Chiappetta, Diomira Tabacco, Amedeo Giuseppe Iaffaldano

|Nov 13, 2021
Masaoka-Koga and TNM Staging System in Thymic Epithelial Tumors: Prognostic Comparison and the Role of the Number of Involved Structures.

Marco Chiappetta, Filippo Lococo, Luca Pogliani

|May 14, 2020
Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives.

Miriam Grazia Ferrara, Vincenzo Di Noia, Ettore D'Argento

Pageof 1

Frequent Collaborators

3 joint publications

Emanuele Vita

2 joint publications

Salvatore Grisanti

2 joint publications

Marco Chiappetta

2 joint publications

Filippo Lococo